Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel Free TLM Stock Alerts

Talisman Metals (TLM) Competitors

GBX 8.95 +0.95 (+11.88%)
As of 07:29 AM Eastern
Compare

TLM vs. IXI, OBD, FAB, NSCI, and CLBX

Should you buy Talisman Metals stock or one of its competitors? Talisman Metals's main competitors and comparable companies include IXICO (IXI), Oxford BioDynamics (OBD), Fusion Antibodies (FAB), NetScientific (NSCI), and Cellbxhealth (CLBX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Talisman Metals compare to IXICO?

Talisman Metals (LON:TLM) and IXICO (LON:IXI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

In the previous week, IXICO had 1 more articles in the media than Talisman Metals. MarketBeat recorded 1 mentions for IXICO and 0 mentions for Talisman Metals. IXICO's average media sentiment score of 0.75 beat Talisman Metals' score of 0.00 indicating that IXICO is being referred to more favorably in the news media.

Company Overall Sentiment
Talisman Metals Neutral
IXICO Positive

Talisman Metals has higher earnings, but lower revenue than IXICO. IXICO is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.72
IXICO£7.28M2.23-£3.58M-£1.95N/A

1.4% of Talisman Metals shares are owned by institutional investors. Comparatively, 30.6% of IXICO shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by insiders. Comparatively, 3.1% of IXICO shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Talisman Metals has a net margin of 0.00% compared to IXICO's net margin of -24.98%. Talisman Metals' return on equity of 0.00% beat IXICO's return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
IXICO -24.98%-16.18%-10.40%

Talisman Metals has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, IXICO has a beta of 0.106, indicating that its share price is 89% less volatile than the broader market.

Summary

Talisman Metals beats IXICO on 8 of the 12 factors compared between the two stocks.

How does Talisman Metals compare to Oxford BioDynamics?

Talisman Metals (LON:TLM) and Oxford BioDynamics (LON:OBD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

1.4% of Talisman Metals shares are owned by institutional investors. Comparatively, 11.7% of Oxford BioDynamics shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by company insiders. Comparatively, 52.8% of Oxford BioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Oxford BioDynamics had 1 more articles in the media than Talisman Metals. MarketBeat recorded 1 mentions for Oxford BioDynamics and 0 mentions for Talisman Metals. Talisman Metals' average media sentiment score of 0.00 equaled Oxford BioDynamics'average media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Oxford BioDynamics Neutral

Talisman Metals has higher earnings, but lower revenue than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.72
Oxford BioDynamics£1.20M3.95-£103.52M-£0.20N/A

Talisman Metals has a net margin of 0.00% compared to Oxford BioDynamics' net margin of -825.61%. Talisman Metals' return on equity of 0.00% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
Oxford BioDynamics -825.61%-451.74%-56.23%

Talisman Metals has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Oxford BioDynamics has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market.

Summary

Talisman Metals beats Oxford BioDynamics on 8 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to Fusion Antibodies?

Talisman Metals (LON:TLM) and Fusion Antibodies (LON:FAB) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

In the previous week, Fusion Antibodies had 2 more articles in the media than Talisman Metals. MarketBeat recorded 2 mentions for Fusion Antibodies and 0 mentions for Talisman Metals. Talisman Metals' average media sentiment score of 0.00 equaled Fusion Antibodies'average media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Fusion Antibodies Neutral

Talisman Metals has higher earnings, but lower revenue than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.72
Fusion Antibodies£1.60M9.57-£4.10M-£1.50N/A

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 7.6% of Fusion Antibodies shares are held by institutional investors. 95.2% of Talisman Metals shares are held by insiders. Comparatively, 5.9% of Fusion Antibodies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Talisman Metals has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Fusion Antibodies has a beta of 1.244, indicating that its share price is 24% more volatile than the broader market.

Talisman Metals has a net margin of 0.00% compared to Fusion Antibodies' net margin of -54.45%. Talisman Metals' return on equity of 0.00% beat Fusion Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
Fusion Antibodies -54.45%-97.87%-63.78%

Summary

Talisman Metals beats Fusion Antibodies on 7 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to NetScientific?

Talisman Metals (LON:TLM) and NetScientific (LON:NSCI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

Talisman Metals has a net margin of 0.00% compared to NetScientific's net margin of -182.91%. Talisman Metals' return on equity of 0.00% beat NetScientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
NetScientific -182.91%-13.70%-9.42%

In the previous week, Talisman Metals' average media sentiment score of 0.00 equaled NetScientific'saverage media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
NetScientific Neutral

1.4% of Talisman Metals shares are owned by institutional investors. Comparatively, 14.7% of NetScientific shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by company insiders. Comparatively, 42.4% of NetScientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, NetScientific has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market.

Talisman Metals has higher earnings, but lower revenue than NetScientific. NetScientific is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.72
NetScientific£1.45M0.00-£2.64M-£0.11N/A

Summary

Talisman Metals beats NetScientific on 7 of the 10 factors compared between the two stocks.

How does Talisman Metals compare to Cellbxhealth?

Talisman Metals (LON:TLM) and Cellbxhealth (LON:CLBX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
Cellbxhealth N/A N/A N/A

In the previous week, Talisman Metals' average media sentiment score of 0.00 equaled Cellbxhealth'saverage media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
Cellbxhealth Neutral

1.4% of Talisman Metals shares are owned by institutional investors. Comparatively, 0.4% of Cellbxhealth shares are owned by institutional investors. 95.2% of Talisman Metals shares are owned by company insiders. Comparatively, 1.2% of Cellbxhealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cellbxhealth has higher revenue and earnings than Talisman Metals. Cellbxhealth is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.72
Cellbxhealth£1.15M8.88N/A-£3.49N/A

Summary

Talisman Metals beats Cellbxhealth on 5 of the 6 factors compared between the two stocks.

Get Talisman Metals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLM vs. The Competition

Export
MetricTalisman MetalsBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£5.74M£3.98B£7.32B£2.89B
Dividend Yield0.83%3.63%2.52%6.22%
P/E Ratio0.7213.88274.06366.55
Price / SalesN/A1,343.72637.8190,071.63
Price / Cash1.00113.2977.8027.89
Price / Book3.7115.2110.406.35
Net Income-£1.35M-£22.82M£3.49B£5.89B
7 Day Performance19.33%-1.72%-0.69%0.24%
1 Month Performance29.24%-6.17%-3.18%6.42%
1 Year PerformanceN/A30.66%15.13%19.37%

Talisman Metals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLM
Talisman Metals
N/AGBX 8.95
+11.9%		N/AN/A£5.74MN/A0.725
IXI
IXICO
N/AGBX 8
+6.7%		N/A-35.7%£16.42M£7.28MN/A79
OBD
Oxford BioDynamics
N/AGBX 0.12
flat		N/A-74.8%£15.46M£1.20MN/A45
FAB
Fusion Antibodies
N/AGBX 11
+2.3%		N/A-38.2%£13.45M£1.60MN/A24
NSCI
NetScientific
N/AN/AN/AN/A£12.81M£1.45MN/A26

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TLM) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
On October 7th, your “safest” assets are at risk
Jeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...
Brownstone Research | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel